AVAIL-T: A Phase 2a Trial of Avelumab, and Anti-PD-L1 Antibody, in Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL)

Matthew J. Ahearne, Charlotte Gaskell, Aimee E. Jackson, Clare Morland, Louise Hopkins, Nadia Nawaz, Matthew A. Timmins, Christopher P. Fox, Graham P. Collins, Andrew Davies, David John Lewis, Kate Cwynarski, Kim Linton, Pam Mckay, Rod Johnson, Simon D. Wagner